Works matching IS 09054383 AND DT 2025 AND VI 41 AND IP 2
Results: 9
Comparison of Minimal Erythema Dose Between Affected and Unaffected Skin in Vitiligo Patients With Fitzpatrick Skin Phototypes III, IV, and V.
- Published in:
- Photodermatology, Photoimmunology & Photomedicine, 2025, v. 41, n. 2, p. 1, doi. 10.1111/phpp.70015
- By:
- Publication type:
- Article
Photosensitizing Drugs and Risk of Skin Cancer in Women—A Prospective Population‐Based Study.
- Published in:
- Photodermatology, Photoimmunology & Photomedicine, 2025, v. 41, n. 2, p. 1, doi. 10.1111/phpp.70013
- By:
- Publication type:
- Article
Combination of Methyl Aminolevulinate‐Based Photodynamic Therapy and Antibiotics in the Treatment of Mycobacterium gordonae Scalp Infection: A Case Report.
- Published in:
- Photodermatology, Photoimmunology & Photomedicine, 2025, v. 41, n. 2, p. 1, doi. 10.1111/phpp.70012
- By:
- Publication type:
- Article
Topical Photodynamic Therapy in a Medical Centre: The Scottish Dermatology Experience.
- Published in:
- Photodermatology, Photoimmunology & Photomedicine, 2025, v. 41, n. 2, p. 1, doi. 10.1111/phpp.70010
- By:
- Publication type:
- Article
Lemon Balm (Melissa officinalis L.) Leaf Extract Promotes Endo180 Production in Dermal Fibroblasts and has Antiwrinkle Effect on Human Skin.
- Published in:
- Photodermatology, Photoimmunology & Photomedicine, 2025, v. 41, n. 2, p. 1, doi. 10.1111/phpp.70006
- By:
- Publication type:
- Article
The Therapeutic and Preventive Effects of Light‐Emitting Diode (LED) for Post‐Inflammatory Erythema and Hyperpigmentation: A Pilot Study.
- Published in:
- Photodermatology, Photoimmunology & Photomedicine, 2025, v. 41, n. 2, p. 1, doi. 10.1111/phpp.70003
- By:
- Publication type:
- Article
Ultraviolet A1‐LED Phototherapy for the Treatment of Palmoplantar Pustulosis.
- Published in:
- Photodermatology, Photoimmunology & Photomedicine, 2025, v. 41, n. 2, p. 1, doi. 10.1111/phpp.13017
- By:
- Publication type:
- Article
German Cohort Observational Study to Investigate the Short‐ and Long‐Term Safety and Clinical Effectiveness of Afamelanotide 16 mg (SCENESSE) in Patients With Erythropoietic Protoporphyria (EPP).
- Published in:
- Photodermatology, Photoimmunology & Photomedicine, 2025, v. 41, n. 2, p. 1, doi. 10.1111/phpp.13012
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Photodermatology, Photoimmunology & Photomedicine, 2025, v. 41, n. 2, p. 1, doi. 10.1111/phpp.12980
- Publication type:
- Article